VCLS’ in silico Team WIN the TOPRA Award for Innovation
This prestigious international award honors those who have made an outstanding achievement in the successful deployment and implementation of innovative ideas within the regulatory science community.
The Team was nominated by Thierry Marchal, Secretary-General, Avicenna Alliance Program Director for Healthcare Solutions and Ansys eHealth expert to the European Commission. Marchal commented, “The VCLS in silico Team has been instrumental in helping us, the Avicenna Alliance, achieve the objective – to ensure safe, affordable, and cost-effective healthcare through the large-scale adoption of in silico medicine.”
The awards are judged by an esteemed panel of industry leaders and experts from around the globe.
“In silico medicine” is the use of subject-specific computer modelling and simulation in healthcare. It is an entirely new type of scientific evidence; all sources of evidence are models. It creates a paradigm shift: to ensure safe, affordable a cost-effective healthcare through the large-scale adoption of in silico medicine.